
Medical Exoskeleton Market - Global Outlook & Forecast 2022-2027
Description
Medical Exoskeleton Market - Global Outlook & Forecast 2022-2027
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Medical Exoskeleton Market Report
The medical exoskeleton market by revenue is expected to grow at a CAGR of over 36% during the period 2022–2027.
Government is responsible for ensuring that exoskeleton products sold in its region are accepted and meet market requirements. As a result, the government has enacted appropriate legislation to ensure that goals are achieved, product safety is the primary objective, and that the sale of unsafe products does not harm citizens. However, if commercialization involves technical product developments, a technical, regulatory framework in which the appropriate regional authorities enact legislation applicable to all levels of government (national, state, state, local, etc.) covering product services and actions. Governments and regulators' safety is a major concern before new products are generally commercially available. In this regard, only a few exoskeletons such as ReWalk, Ekso Bionics, and Cyberdyne have been certified to comply with the evolving international safety guidelines in medical and non-medical applications essential for the market growth.
The following factors are likely to contribute to the growth of the medical exoskeleton market.
This research report includes a detailed segmentation by:
1. What is the size of the medical exoskeleton market and growth rate during the forecast period?
2. Which region is generating the largest revenue in the medical exoskeleton market?
3. Who are the key players in the medical exoskeleton market?
4. What are the factors driving the market growth for the medical exoskeleton market?
5. What are the opportunities in the medical exoskeleton market?
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Medical Exoskeleton Market Report
The medical exoskeleton market by revenue is expected to grow at a CAGR of over 36% during the period 2022–2027.
Government is responsible for ensuring that exoskeleton products sold in its region are accepted and meet market requirements. As a result, the government has enacted appropriate legislation to ensure that goals are achieved, product safety is the primary objective, and that the sale of unsafe products does not harm citizens. However, if commercialization involves technical product developments, a technical, regulatory framework in which the appropriate regional authorities enact legislation applicable to all levels of government (national, state, state, local, etc.) covering product services and actions. Governments and regulators' safety is a major concern before new products are generally commercially available. In this regard, only a few exoskeletons such as ReWalk, Ekso Bionics, and Cyberdyne have been certified to comply with the evolving international safety guidelines in medical and non-medical applications essential for the market growth.
The following factors are likely to contribute to the growth of the medical exoskeleton market.
- The Emergence of Soft Actuator Medical Exoskeletons
- Focus on Development of 3D- Printed Medical Exoskeletons
- Increasing Focus on Developing Brain-Machine Interface Based Medical Exoskeleton
- Increasing Number of People with Physical Disabilities
- Recent Advancements in the Medical Exoskeleton
- Increasing Insurance Coverage for Medical Exoskeleton
- Wearable robots and exoskeletons are used to assist in personal mobility. Exoskeletons deliver high-quality rehabilitation, thereby providing the base for a growth strategy for clinical facilities in the medical exoskeleton market.
- 3D printing exoskeletons allow designing and producing parts with complex shapes and geometries without waste or composite materials. This technology gives the manufacturer design freedom and allows us to design customer-specific products in small quantities and at a low cost.
This research report includes a detailed segmentation by:
- Modality
- Extremity
- Mobility
- Usage
- Geography
- Powered exoskeletons accounted for the larger share of the overall exoskeleton market in 2020. The high cost of powered exoskeletons leads to a higher market share of the technology than passive exoskeletons. Passive exoskeletons are often cheaper and lighter than powered exoskeleton, thereby, the combination of powered and passive exoskeleton characteristics in a new class of pseudo-passive (or semi-active) devices may provide a promising future direction for exoskeleton technology.
- The ReWalk exoskeleton developed by ReWalk Robotics (Marlborough, MA, US) is a LEE that enables motorized movement of the hip and knee so that people with SCI can stand and walk upright. It is the first exoskeleton suit, approved by the US Food and Drug Administration in 2014, that can be used as a personal device at home and in the community, which propel the market's growth.
- Powered Exoskeletons
- Passive Exoskeletons
- Lower Extremity Exoskeletons
- Upper Extremity Exoskeletons
- Mobile Exoskeletons
- Stationary Exoskeletons
- Rehabilitation Exoskeletons
- Augmentation Exoskeletons
- Massachusetts-based exoskeleton maker ReWalk Robotics. The company`s latest product, the augmentative ReWalk 6.0, uses cutting-edge technology to allow individuals with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, to stand, turn and walk.
- Ekso Bionics, a Singapore-based company, announces a partnership with Australia's Royal Rehab to further expand the use of robotic exoskeletons in the Asia-Pacific region.
- California's Ekso Bionics' Ekso GT is also a major rehabilitation exoskeleton, equipped with smart assist software, the physiotherapist can change the support for each leg device individually. This ability allows Ekso GT to rehabilitate more patients, from those too weak to walk to those who are almost independent, eventually for the market's growth.
- Ekso bionics
- ReWalk Robotics
- PARKER HANNIFIN
- Ottobock
- CYBERDYNE
- Rex Bionics
- DIH Medical
- Wearable Robotics
- Gogoa
- ExoAtlet
- Panasonic
- Tyromotion
- Honda Motor
- B-Temia
- Bionic Power
- ANGEL ROBOTICS
- AXOSUITS
- BAMA Teknoloji
- Biomotum
- Bionic Yantra
- Bioservo Technologies
- Fourier Intelligence
- FREE Bionics
- Gloreha Idrogenet
- Harmonic Bionics
- HEXAR Humancare
- Human in Motion Robotics
- InteSpring
- MARSI BIONICS
- The reason for the high uptake of the medical exoskeleton market in North America was contributed by the factors of the increasing elderly population, the prevalence of chronic illness, increasing strokes, rise in the number of the rehabilitation center, rise in prescriptions and hospitalization rates, increase in government funding and healthcare expenditure, as well as growing awareness of technological developments. The strong presence of key medical exoskeleton players is also another reason for the high uptake of the medical exoskeleton in North America.
- APAC has a growing number of exoskeleton developers actively involved in the development of innovative medical exoskeletons at affordable cost. APAC is projected to grow at a lucrative rate due to an increase in stroke incidence, a growing aging population, related health conditions, favorable government policies, increasing healthcare expenditures are some of the factors driving the market.
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- APAC
- China
- Japan
- India
- Australia
- South Korea
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East and Africa
- Turkey
- Saudi Arabia
- South Africa
1. What is the size of the medical exoskeleton market and growth rate during the forecast period?
2. Which region is generating the largest revenue in the medical exoskeleton market?
3. Who are the key players in the medical exoskeleton market?
4. What are the factors driving the market growth for the medical exoskeleton market?
5. What are the opportunities in the medical exoskeleton market?
Table of Contents
281 Pages
- 1 Research Methodology
- 2 Research Objectives
- 3 Research Process
- 4 Scope & Coverage
- 4.1 Market Definition
- 4.1.1 Inclusions
- 4.1.2 Exclusions
- 4.1.3 Market Estimation Caveats
- 4.2 Base Year
- 4.3 Scope of The Study
- 4.4 Market Segmentation
- 4.4.1 Market Segmentation by Modality
- 4.4.2 Market Segmentation by Extremity
- 4.4.3 Market Segmentation by Mobility
- 4.4.4 Market Segmentation by Type
- 4.4.5 Market Segmentation by Geography
- 5 Report Assumptions & Caveats
- 5.1 Key Caveats
- 5.2 Currency Conversion
- 5.3 Market Derivation
- 6 Market at a Glance
- 7 Introduction
- 7.1 Overview
- 8 Market Opportunities & Trends
- 8.1 Emergence of Soft Actuator Medical Exoskeletons
- 8.2 Development Of 3d-Printed Medical Exoskeletons
- 8.3 Increasing Focus on Brain-Machine Interface Based Medical Exoskeletons
- 9 Market Growth Enablers
- 9.1 Increasing Number of People with Physical Disabilities
- 9.2 Recent Advancements in Medical Exoskeletons
- 9.3 Increasing Insurance Coverage for Medical Exoskeletons
- 10 Market Restraints
- 10.1 High Cost of Medical Exoskeletons
- 10.2 Greater Preference for Wheelchairs
- 11 Market Landscape
- 11.1 Market Overview
- 11.2 Market Size & Forecast
- 11.3 Five Forces Analysis
- 11.3.1 Threat of New Entrants
- 11.3.2 Bargaining Power of Suppliers
- 11.3.3 Bargaining Power of Buyers
- 11.3.4 Threat of Substitutes
- 11.3.5 Competitive Rivalry
- 12 Modality
- 12.1 Market Snapshot & Growth Engine
- 12.2 Market Overview
- 12.3 Powered Exoskeleton
- 12.3.1 Market Overview
- 12.3.2 Market Size & Forecast
- 12.3.3 Powered Exoskeleton: Geography Segmentation
- 12.4 Passive Exoskeleton
- 12.4.1 Market Overview
- 12.4.2 Market Size & Forecast
- 12.4.3 Passive Exoskeleton: Geography Segmentation
- 13 Extremity
- 13.1 Market Snapshot & Growth Engine
- 13.2 Market Overview
- 13.3 Lower Extremity Exoskeletons
- 13.3.1 Market Overview
- 13.3.2 Market Size & Forecast
- 13.3.3 Lower Extremity Exoskeleton: Geography Segmentation
- 13.4 Upper Extremity Exoskeletons
- 13.4.1 Market Overview
- 13.4.2 Market Size & Forecast
- 13.4.3 Upper Extremity Exoskeleton: Geography Segmentation
- 14 Mobility
- 14.1 Market Snapshot & Growth Engine
- 14.2 Market Overview
- 14.3 Mobile Exoskeletons
- 14.3.1 Market Overview
- 14.3.2 Market Size & Forecast
- 14.3.3 Mobile Exoskeleton: Geography Segmentation
- 14.4 Stationary Exoskeletons
- 14.4.1 Market Overview
- 14.4.2 Market Size & Forecast
- 14.4.3 Stationary Exoskeleton: Geography Segmentation
- 15 Type
- 15.1 Market Snapshot & Growth Engine
- 15.2 Market Overview
- 15.3 Rehabilitation Exoskeletons
- 15.3.1 Market Overview
- 15.3.2 Market Size & Forecast
- 15.3.3 Rehabilitation Exoskeleton: Geography Segmentation
- 15.4 Augmentation Exoskeletons
- 15.4.1 Market Overview
- 15.4.2 Market Size & Forecast
- 15.4.3 Augmentation Exoskeleton: Geography Segmentation
- 16 Geography
- 16.1 Market Snapshot & Growth Engine
- 16.2 Geographic Overview
- 17 North America
- 17.1 Market Overview
- 17.2 Market Size & Forecast
- 17.2.1 North America: Modality Segmentation
- 17.2.2 North America: Extremity Segmentation
- 17.2.3 North America: Mobility Segmentation
- 17.2.4 North America: Type Segmentation
- 17.3 Key Countries
- 17.3.1 US: Market Size & Forecast
- 17.3.2 Canada: Market Size & Forecast
- 18 Europe
- 18.1 Market Overview
- 18.2 Market Size & Forecast
- 18.2.1 Europe: Modality Segmentation
- 18.2.2 Europe: Extremity Segmentation
- 18.2.3 Europe: Mobility Segmentation
- 18.2.4 Europe: Type Segmentation
- 18.3 Key Countries
- 18.3.1 Germany: Market Size & Forecast
- 18.3.2 UK: Market Size & Forecast
- 18.3.3 France: Market Size & Forecast
- 18.3.4 Spain: Market Size & Forecast
- 18.3.5 Italy: Market Size & Forecast
- 19 APAC
- 19.1 Market Overview
- 19.2 Market Size & Forecast
- 19.2.1 APAC: Modality Segmentation
- 19.2.2 APAC: Extremity Segmentation
- 19.2.3 APAC: Mobility Segmentation
- 19.2.4 APAC: Type Segmentation
- 19.3 Key Countries
- 19.3.1 China: Market Size & Forecast
- 19.3.2 Japan: Market Size & Forecast
- 19.3.3 India: Market Size & Forecast
- 19.3.4 Australia: Market Size & Forecast
- 19.3.5 South Korea: Market Size & Forecast
- 20 Latin America
- 20.1 Market Overview
- 20.2 Market Size & Forecast
- 20.2.1 Latin America: Modality Segmentation
- 20.2.2 Latin America: Extremity Segmentation
- 20.2.3 Latin America: Mobility Segmentation
- 20.2.4 Latin America: Type Segmentation
- 20.3 Key Countries
- 20.3.1 Brazil: Market Size & Forecast
- 20.3.2 Mexico: Market Size & Forecast
- 20.3.3 Argentina: Market Size & Forecast
- 21 Middle East & Africa
- 21.1 Market Overview
- 21.2 Market Size & Forecast
- 21.2.1 Middle East & Africa: Modality Segmentation
- 21.2.2 Middle East & Africa: Extremity Segmentation
- 21.2.3 Middle East & Africa: Mobility Segmentation
- 21.2.4 Middle East & Africa: Type Segmentation
- 21.3 Key Countries
- 21.3.1 Turkey: Market Size & Forecast
- 21.3.2 Saudi Araba: Market Size & Forecast
- 21.3.3 South Africa: Market Size & Forecast
- 22 Competitive Landscape
- 22.1 Competition Overview
- 22.2 Market Share Analysis
- 23 Key Company Profiles
- 23.1 EKSO BIONICS
- 23.1.1 Business Overview
- 23.1.2 Ekso Bionics in The Medical Exoskeleton Market
- 23.1.3 Product Offerings
- 23.1.4 Key Strategies
- 23.1.5 Key Strengths
- 23.1.6 Key Opportunities
- 23.2 REWALK ROBOTICS
- 23.2.1 Business Overview
- 23.2.2 Rewalk Robotics in The Medical Exoskeleton Market
- 23.2.3 Product Offerings
- 23.2.4 Key Strategies
- 23.2.5 Key Strengths
- 23.2.6 Key Opportunities
- 23.3 PARKER-HANNIFIN
- 23.3.1 Business Overview
- 23.3.2 Parker Hannifin in The Medical Exoskeleton Market
- 23.3.3 Product Offerings
- 23.3.4 Key Strategies
- 23.3.5 Key Strengths
- 23.3.6 Key Opportunities
- 23.4 OTTOBOCK
- 23.4.1 Business Overview
- 23.4.2 Ottobock in The Medical Exoskeleton Market
- 23.4.3 Product Offerings
- 23.4.4 Key Strategies
- 23.4.5 Key Strengths
- 23.4.6 Key Opportunities
- 23.5 CYBERDYNE
- 23.5.1 Business Overview
- 23.5.2 Cyberdyne in The Medical Exoskeleton Market
- 23.5.3 Product Offerings
- 23.5.4 Key Strategies
- 23.5.5 Key Strengths
- 23.5.6 Key Opportunities
- 23.6 REX BIONICS
- 23.6.1 Business Overview
- 23.6.2 Rex Bionics in Medical Exoskeleton
- 23.6.3 Product Offerings
- 23.6.4 Key Strategies
- 23.6.5 Key Strengths
- 23.6.6 Key Opportunities
- 23.7 DIH MEDICAL
- 23.7.1 Business Overview
- 23.7.2 Dih Medical in The Medical Exoskeleton Market
- 23.7.3 Product Offerings
- 23.7.4 Key Strategies
- 23.7.5 Key Strengths
- 23.7.6 Key Opportunities
- 24 Other Prominent Vendors
- 24.1 WEARABLE ROBOTICS
- 24.1.1 Business Overview
- 24.1.2 Product Offerings
- 24.2 GOGOA
- 24.2.1 Business Overview
- 24.2.2 Product Offerings
- 24.3 EXOATLET
- 24.3.1 Business Overview
- 24.3.2 Product Offerings
- 24.4 PANASONIC
- 24.4.1 Business Overview
- 24.4.2 Product Offerings
- 24.5 TYROMOTION
- 24.5.1 Business Overview
- 24.5.2 Product Offerings
- 24.6 HONDA
- 24.6.1 Business Overview
- 24.6.2 Product Offerings
- 24.7 B-TEMIA
- 24.7.1 Business Overview
- 24.7.2 Product Offerings
- 24.8 BIONIC POWER
- 24.8.1 Business Overview
- 24.8.2 Product Offerings
- 24.9 ANGEL ROBOTICS
- 24.9.1 Business Overview
- 24.9.2 Product Offerings
- 24.10 AXOSUITS
- 24.10.1 Business Overview
- 24.10.2 Product Offerings
- 24.11 BAMA TEKNOLOJI
- 24.11.1 Business Overview
- 24.11.2 Product Offerings
- 24.12 BIOMOTUM
- 24.12.1 Business Overview
- 24.12.2 Product Offerings
- 24.13 BIONIC YANTRA
- 24.13.1 Business Overview
- 24.13.2 Product Offerings
- 24.14 BIOSERVO TECHNOLOGIES
- 24.14.1 Business Overview
- 24.14.2 Product Offerings
- 24.15 FOURIER INTELLIGENCE
- 24.15.1 Business Overview
- 24.15.2 Product Offerings
- 24.16 FREE BIONICS
- 24.16.1 Business Overview
- 24.16.2 Product Offerings
- 24.17 GLOREHA IDROGENET
- 24.17.1 Business Overview
- 24.17.2 Product Offerings
- 24.18 HARMONIC BIONICS
- 24.18.1 Business Overview
- 24.18.2 Product Offerings
- 24.19 HEXAR HUMANCARE
- 24.19.1 Business Overview
- 24.19.2 Product Offerings
- 24.20 HUMAN IN MOTION ROBOTICS
- 24.20.1 Business Overview
- 24.20.2 Product Offerings
- 24.21 INTESPRING
- 24.21.1 Business Overview
- 24.21.2 Product Offerings
- 24.22 MARSI BIONICS
- 24.22.1 Business Overview
- 24.22.2 Product Offerings
- 25 Report Summary
- 25.1 Key Takeaways
- 25.2 Strategic Recommendations
- 26 Quantitative Summary
- 26.1 Market by Modality
- 26.1.1 North America: Modality Segmentation
- 26.1.2 Europe: Modality Segmentation
- 26.1.3 APAC: Modality Segmentation
- 26.1.4 Latin America: Modality Segmentation
- 26.1.5 Middle East & Africa: Modality Segmentation
- 26.2 Market by Extremity
- 26.2.1 North America: Extremity Segmentation
- 26.2.2 Europe: Extremity Segmentation
- 26.2.3 APAC: Extremity Segmentation
- 26.2.4 Latin America: Extremity Segmentation
- 26.2.5 Middle East & Africa: Extremity Segmentation
- 26.3 Market by Mobility
- 26.3.1 North America: Mobility Segmentation
- 26.3.2 Europe: Mobility Segmentation
- 26.3.3 APAC: Mobility Segmentation
- 26.3.4 Latin America: Mobility Segmentation
- 26.3.5 Middle East & Africa: Mobility Segmentation
- 26.4 Market by Type
- 26.4.1 North America: Type Segmentation
- 26.4.2 Europe: Type Segmentation
- 26.4.3 APAC: Type Segmentation
- 26.4.4 Latin America: Type Segmentation
- 26.4.5 Middle East & Africa: Type Segmentation
- 26.5 Market by Geography
- 26.5.1 Powered Exoskeleton
- 26.5.2 Passive Exoskeleton
- 26.5.3 Upper Extremity Exoskeleton
- 26.5.4 Lower Extremity Exoskeleton
- 26.5.5 Stationary Exoskeleton
- 26.5.6 Mobile Exoskeleton
- 26.5.7 Rehabilitation Exoskeleton
- 26.5.8 Augmentation Exoskeleton
- 27 Appendix
- 27.1 Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.